Allurion Technologies (ALUR) Competitors $2.14 -0.05 (-2.24%) Closing price 03:58 PM EasternExtended Trading$2.14 +0.00 (+0.19%) As of 06:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ALUR vs. QTI, TELA, CTSO, SURG, PYPD, DXR, SRTS, APT, CTCX, and PSTVShould you be buying Allurion Technologies stock or one of its competitors? The main competitors of Allurion Technologies include QT Imaging (QTI), TELA Bio (TELA), Cytosorbents (CTSO), SurgePays (SURG), PolyPid (PYPD), Daxor (DXR), Sensus Healthcare (SRTS), Alpha Pro Tech (APT), Carmell (CTCX), and Plus Therapeutics (PSTV). These companies are all part of the "medical equipment" industry. Allurion Technologies vs. Its Competitors QT Imaging TELA Bio Cytosorbents SurgePays PolyPid Daxor Sensus Healthcare Alpha Pro Tech Carmell Plus Therapeutics Allurion Technologies (NYSE:ALUR) and QT Imaging (NASDAQ:QTI) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, earnings, dividends, profitability, valuation, risk, media sentiment and analyst recommendations. Do analysts rate ALUR or QTI? Allurion Technologies presently has a consensus price target of $22.83, suggesting a potential upside of 966.48%. Given Allurion Technologies' stronger consensus rating and higher possible upside, equities research analysts plainly believe Allurion Technologies is more favorable than QT Imaging.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Allurion Technologies 0 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.50QT Imaging 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Do institutionals & insiders hold more shares of ALUR or QTI? 21.4% of Allurion Technologies shares are held by institutional investors. Comparatively, 24.2% of QT Imaging shares are held by institutional investors. 22.4% of Allurion Technologies shares are held by insiders. Comparatively, 75.4% of QT Imaging shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Which has more risk & volatility, ALUR or QTI? Allurion Technologies has a beta of -0.46, indicating that its share price is 146% less volatile than the S&P 500. Comparatively, QT Imaging has a beta of -0.2, indicating that its share price is 120% less volatile than the S&P 500. Which has higher earnings & valuation, ALUR or QTI? QT Imaging has lower revenue, but higher earnings than Allurion Technologies. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAllurion Technologies$19.92M0.83-$7.20M-$12.53-0.17QT Imaging$4.00M16.84-$4.03MN/AN/A Is ALUR or QTI more profitable? QT Imaging has a net margin of 0.00% compared to Allurion Technologies' net margin of -158.30%. Company Net Margins Return on Equity Return on Assets Allurion Technologies-158.30% N/A -59.91% QT Imaging N/A N/A -65.94% Does the media prefer ALUR or QTI? In the previous week, Allurion Technologies had 2 more articles in the media than QT Imaging. MarketBeat recorded 2 mentions for Allurion Technologies and 0 mentions for QT Imaging. QT Imaging's average media sentiment score of 0.00 beat Allurion Technologies' score of -0.01 indicating that QT Imaging is being referred to more favorably in the news media. Company Overall Sentiment Allurion Technologies Neutral QT Imaging Neutral SummaryQT Imaging beats Allurion Technologies on 7 of the 13 factors compared between the two stocks. Get Allurion Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for ALUR and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ALUR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ALUR vs. The Competition Export to ExcelMetricAllurion TechnologiesMED PRODUCTS IndustryMedical SectorNYSE ExchangeMarket Cap$16.62M$10.45B$5.69B$21.37BDividend YieldN/A1.86%5.72%3.49%P/E Ratio-0.1721.3875.8629.83Price / Sales0.8328.37489.9288.70Price / CashN/A25.0025.8118.13Price / Book-0.073.4312.844.58Net Income-$7.20M$212.47M$3.28B$998.53M7 Day Performance-1.15%-1.00%0.20%1.07%1 Month Performance-10.98%2.17%4.59%4.41%1 Year Performance-84.94%-10.94%68.31%14.45% Allurion Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ALURAllurion Technologies2.2191 of 5 stars$2.14-2.2%$22.83+966.5%-85.9%$16.62M$19.92M-0.17501Short Interest ↑QTIQT ImagingN/A$2.48+0.8%N/A+388.0%$67.29M$4.00M0.00N/ATELATELA Bio2.6831 of 5 stars$1.62+1.9%$4.50+177.8%-40.4%$62.99M$69.30M-1.45120Positive NewsCTSOCytosorbents2.798 of 5 stars$0.98+1.7%$5.50+459.9%-15.3%$60.60M$36.11M-5.78220News CoveragePositive NewsAnalyst ForecastSURGSurgePays3.095 of 5 stars$2.76+0.7%$9.00+226.1%+81.5%$55.98M$60.88M-1.1140Negative NewsPYPDPolyPid3.498 of 5 stars$3.46+0.3%$12.40+258.4%-2.2%$54.85MN/A-0.9080News CoveragePositive NewsShort Interest ↓Gap UpDXRDaxor4.0785 of 5 stars$11.41+3.2%$25.00+119.1%+28.8%$53.50MN/A0.0037News CoverageShort Interest ↓Gap DownSRTSSensus Healthcare2.7374 of 5 stars$3.23flat$8.00+147.7%-48.3%$53.10M$41.81M-53.8340APTAlpha Pro Tech2.7247 of 5 stars$4.89flatN/A-14.6%$51.21M$58.56M13.22120Positive NewsCTCXCarmellN/A$2.43-4.7%N/A+307.7%$50.80M$32.84K0.0014PSTVPlus Therapeutics3.2062 of 5 stars$0.48-2.8%$7.88+1,548.2%-72.1%$48.78M$5.82M-0.2120Short Interest ↑ Related Companies and Tools Related Companies QT Imaging Competitors TELA Bio Competitors Cytosorbents Competitors SurgePays Competitors PolyPid Competitors Daxor Competitors Sensus Healthcare Competitors Alpha Pro Tech Competitors Carmell Competitors Plus Therapeutics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:ALUR) was last updated on 9/16/2025 by MarketBeat.com Staff From Our PartnersFanatics Hit $31B-Is This Nasdaq Next?Fanatics built an empire by owning the fan experience-scaling to a $31B valuation. But the next wave isn't abo...i2i Marketing Group, LLC | SponsoredWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...SmartAsset | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | SponsoredFree: The Crypto Summit That Could Change Your LifeWall Street’s Crypto Playbook—Revealed at This Free Event If you want to understand what's really happening...Crypto 101 Media | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredOpenAI’s new $300 billion dealOpenAI just signed a $300 billion cloud deal with Oracle to secure the computing power needed for its next Cha...Porter & Company | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Allurion Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Allurion Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ALUR Stock Alerts